SK282914B6 - Sertralínová dávkovacia forma - Google Patents

Sertralínová dávkovacia forma Download PDF

Info

Publication number
SK282914B6
SK282914B6 SK1805-99A SK180599A SK282914B6 SK 282914 B6 SK282914 B6 SK 282914B6 SK 180599 A SK180599 A SK 180599A SK 282914 B6 SK282914 B6 SK 282914B6
Authority
SK
Slovakia
Prior art keywords
sertraline
dosage form
mga
oil
vehicle
Prior art date
Application number
SK1805-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK180599A3 (en
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282914(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SK180599A3 publication Critical patent/SK180599A3/sk
Publication of SK282914B6 publication Critical patent/SK282914B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK1805-99A 1997-07-01 1998-06-16 Sertralínová dávkovacia forma SK282914B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (2)

Publication Number Publication Date
SK180599A3 SK180599A3 (en) 2001-01-18
SK282914B6 true SK282914B6 (sk) 2003-01-09

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1805-99A SK282914B6 (sk) 1997-07-01 1998-06-16 Sertralínová dávkovacia forma

Country Status (40)

Country Link
EP (1) EP0980241B1 (zh)
JP (1) JP3585245B2 (zh)
KR (1) KR100371730B1 (zh)
CN (1) CN1261792A (zh)
AP (1) AP945A (zh)
AR (1) AR015916A1 (zh)
AT (1) ATE256457T1 (zh)
AU (1) AU724635B2 (zh)
BG (1) BG103917A (zh)
BR (1) BR9809712A (zh)
CA (1) CA2290973C (zh)
CO (1) CO4940405A1 (zh)
DE (1) DE69820608T2 (zh)
DK (1) DK0980241T3 (zh)
DZ (1) DZ2544A1 (zh)
EA (1) EA001905B1 (zh)
ES (1) ES2210760T3 (zh)
GT (1) GT199800090A (zh)
HR (1) HRP980378B1 (zh)
HU (1) HUP0002250A3 (zh)
ID (1) ID24673A (zh)
IL (1) IL133075A0 (zh)
IS (1) IS5266A (zh)
MA (1) MA24586A1 (zh)
MY (1) MY119728A (zh)
NO (1) NO996492L (zh)
NZ (1) NZ501252A (zh)
OA (1) OA11246A (zh)
PA (1) PA8454001A1 (zh)
PE (1) PE97299A1 (zh)
PL (1) PL337807A1 (zh)
PT (1) PT980241E (zh)
SK (1) SK282914B6 (zh)
TN (1) TNSN98123A1 (zh)
TR (1) TR199903282T2 (zh)
TW (1) TW382597B (zh)
UA (1) UA68350C2 (zh)
UY (1) UY25070A1 (zh)
WO (1) WO1999001113A1 (zh)
ZA (1) ZA985709B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348119A1 (en) * 1998-10-13 2002-05-06 Pfizer Prod Inc Sertraline oral concentrate
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
EP1889614A3 (en) 1999-09-03 2010-09-22 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
CN1728982A (zh) * 2002-10-31 2006-02-01 阿尔扎公司 可增加疏水性药物生物利用度的药物制剂
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214276T1 (de) * 1994-09-19 2002-03-15 Du Pont Pharm Co Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
PT768083E (pt) * 1995-07-17 2003-08-29 Pfizer Sertralina para o tratamento de doentes pos-enfarte miocardico

Also Published As

Publication number Publication date
GT199800090A (es) 1999-12-21
UA68350C2 (en) 2004-08-16
CN1261792A (zh) 2000-08-02
TNSN98123A1 (fr) 2005-03-15
NO996492L (no) 2000-02-29
EA001905B1 (ru) 2001-10-22
DE69820608D1 (de) 2004-01-29
PL337807A1 (en) 2000-09-11
AP9801279A0 (en) 1998-06-30
BR9809712A (pt) 2000-07-11
TR199903282T2 (xx) 2000-08-21
MY119728A (en) 2005-07-29
HRP980378B1 (en) 2001-12-31
IL133075A0 (en) 2001-03-19
IS5266A (is) 1999-11-23
UY25070A1 (es) 2000-12-29
PA8454001A1 (es) 2000-05-24
KR100371730B1 (ko) 2003-02-07
HUP0002250A3 (en) 2001-01-29
CA2290973A1 (en) 1999-01-14
EP0980241A1 (en) 2000-02-23
PE97299A1 (es) 1999-10-13
AR015916A1 (es) 2001-05-30
SK180599A3 (en) 2001-01-18
OA11246A (en) 2002-11-19
HRP980378A2 (en) 1999-04-30
ES2210760T3 (es) 2004-07-01
JP3585245B2 (ja) 2004-11-04
DZ2544A1 (fr) 2003-02-08
CO4940405A1 (es) 2000-07-24
NZ501252A (en) 2004-11-26
ZA985709B (en) 2000-01-10
MA24586A1 (fr) 1998-12-31
DE69820608T2 (de) 2004-12-23
BG103917A (bg) 2000-07-31
AP945A (en) 2001-02-28
AU7545098A (en) 1999-01-25
TW382597B (en) 2000-02-21
JP2000512316A (ja) 2000-09-19
WO1999001113A1 (en) 1999-01-14
EA199900963A1 (ru) 2000-08-28
ATE256457T1 (de) 2004-01-15
PT980241E (pt) 2004-03-31
HUP0002250A2 (hu) 2000-12-28
DK0980241T3 (da) 2004-04-05
KR20010013588A (ko) 2001-02-26
ID24673A (id) 2000-07-27
CA2290973C (en) 2003-06-17
AU724635B2 (en) 2000-09-28
NO996492D0 (no) 1999-12-27
EP0980241B1 (en) 2003-12-17

Similar Documents

Publication Publication Date Title
EP0553178B1 (en) Biphasic release formulations for lipophilic drugs
AU692255B2 (en) Self-emulsifiable formulation producing an oil-in-water emulsion
ES2326783T3 (es) Composiciones de n-benzoilestaurosporina espontaneamente dispersables.
ES2238982T3 (es) Formulacion de carbamazepina de liberacion prolongada.
KR19980703423A (ko) 결장 투여용 아자티오프린 조성물
JP2004520398A (ja) 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物
SK282914B6 (sk) Sertralínová dávkovacia forma
JPH0840936A (ja) 経口投与薬物のための製剤
US20120213855A1 (en) Dosage forms for weakly ionizable compounds
JPS63406B2 (zh)
US20030133974A1 (en) Encapsulated solution dosage forms of sertraline
JP2022531685A (ja) メチルナルトレキソンの液体経口投与製剤
JP3277735B2 (ja) ナフトエ酸誘導体の吸収促進組成物
WO1992014443A1 (en) Microsphere-in-oil emulsion
CZ464299A3 (cs) Želatinové zapouzdření roztokové dávkovači formy sertralinu
MXPA99012099A (en) Gelatine encapsulated solution dosage forms of sertraline
WO2012066347A1 (en) Oil based formulations
IE910683A1 (en) Microsphere-in-oil emulsion